Biomx INC DEF 14A proxy statements

BiomX Inc. is holding a special meeting on August 25, 2026, to vote on key proposals including the issuance of stock for an acquisition, a reverse stock split, and auditor ratification.

BiomX Inc. has issued a proxy statement for its 2026 Annual Meeting to elect a director and approve a significant increase in shares reserved for its equity incentive plan.

BiomX Inc. is convening an Extraordinary Special Meeting to approve a new 2026 Equity Incentive Plan, crucial for talent retention amidst recent leadership changes.

BIOMX INC. has filed definitive additional proxy materials with the U.S. Securities and Exchange Commission.

BiomX Inc. will hold its 2025 Annual Meeting to elect directors, ratify auditors, and seek authorization for a reverse stock split to boost share price and facilitate capital raising.

BiomX Inc. has filed a supplement to its definitive proxy statement to correct errors in the beneficial ownership table in advance of its Special Meeting of Stockholders on April 21, 2025.

BiomX Inc. issues a supplement to its definitive proxy statement to correct errors regarding stockholder voting eligibility and the number of Series X Preferred Stock shares outstanding.

BiomX Inc. is holding a special meeting to seek stockholder approval for the exercise of certain warrants into common stock to comply with NYSE American listing rules.

BiomX Inc. is urging stockholders to vote on several critical proposals at its upcoming annual meeting, including a reverse stock split authorization and an increase in authorized common stock shares to facilitate recent acquisitions and future growth.